Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19
Article Sidebar
Main Article Content
Abstract
Background: To evaluate the impact of sex on acute SARS-CoV-2 infection, 668 participants from the ACTIV-2/A5401 study were followed over a 28-day period.
Methods: A primary analysis was performed on 469 participants with quantifiable viral loads at baseline.
Results: Male and female participants had comparable nasal SARS-CoV-2 RNA levels at study entry and throughout follow-up. However, sex-specific differences in viral shedding emerged when stratified by symptom duration. In the first 3 days after symptom onset, female participants exhibited higher nasal SARS-CoV-2 RNA levels than males, but lower viral RNA levels thereafter. The higher viral RNA levels in females during the earliest phase of acute COVID-19 were observed even after adjusting for age, race, and region of enrollment. Female participants also tended to have higher symptom scores across days since symptom onset, but no significant correlation was observed between nasal SARS-CoV-2 RNA levels and symptom score regardless of sex.
Conclusion: These findings highlight the impact of sex on both viral shedding and symptom dynamics and underscore the importance of considering time since symptom onset when evaluating antiviral therapies for respiratory viruses in clinical trials.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Pathogens and Immunity abides by Creative Commons BY 4.0:
http://creativecommons.org/licenses/by/4.0/
This license lets others distribute, remix, tweak, and build upon your work for any lawful purpose, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. The authors maintain copyright of their materal.
*Due to a template error on our pdfs, articles published from May 20, 2016 to June 24, 2022 incorrectly state the copyright is held by Pathogens and Immunity. Copyright of all articles is held by the authors of each article as noted in the above copyright policy.
References
1. Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (Covid-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: 10.1001/jama.2020.2648. PubMed PMID: 32091533.
DOI: https://doi.org/10.1001/jama.2020.26482. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, Ye C, Zhang P, Xing Y, Guo H, Tang W. Risk Factors of Critical & Mortal Covid-19 Cases: A Systematic Literature Review and Meta-Analysis. J Infect. 2020;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. PubMed PMID: 32335169; PMCID: PMC7177098.
DOI: https://doi.org/10.1016/j.jinf.2020.04.0213. Deng G, Yin M, Chen X, Zeng F. Clinical Determinants for Fatality of 44,672 Patients with Covid-19. Crit Care. 2020;24(1):179. doi: 10.1186/s13054-020-02902-w. PubMed PMID: 32345311; PMCID: PMC7187660.
DOI: https://doi.org/10.1186/s13054-020-02902-w4. Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Silva J, Mao T, Oh JE, Tokuyama M, Lu P, Venkataraman A, Park A, Liu F, Meir A, Sun J, Wang EY, Casanovas-Massana A, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ, Yale IRT, Shaw A, Fournier JB, Odio CD, Farhadian S, Dela Cruz C, Grubaugh ND, Schulz WL, Ring AM, Ko AI, Omer SB, Iwasaki A. Sex Differences in Immune Responses That Underlie Covid-19 Disease Outcomes. Nature. 2020;588(7837):315-20. doi: 10.1038/s41586-020-2700-3. PubMed PMID: 32846427; PMCID: PMC7725931.
DOI: https://doi.org/10.1038/s41586-020-2700-35. Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering How Biological Sex Impacts Immune Responses and Covid-19 Outcomes. Nat Rev Immunol. 2020;20(7):442-7. doi: 10.1038/s41577-020-0348-8. PubMed PMID: 32528136; PMCID: PMC7288618.
DOI: https://doi.org/10.1038/s41577-020-0348-86. Puhach O, Meyer B, Eckerle I. Sars-Cov-2 Viral Load and Shedding Kinetics. Nat Rev Microbiol. 2023;21(3):147-61. doi: 10.1038/s41579-022-00822-w. PubMed PMID: 36460930; PMCID: PMC9716513.
7. Huang B, Cai Y, Li N, Li K, Wang Z, Li L, Wu L, Zhu M, Li J, Wu M, Li W, Wu W, Zhang L, Xia X, Wang S, Chen H, Wang Q. Sex-Based Clinical and Immunological Differences in Covid-19. BMC Infect Dis. 2021;21(1):647. doi: 10.1186/s12879-021-06313-2. PubMed PMID: 34225644; PMCID: PMC8256650.
DOI: https://doi.org/10.1186/s12879-021-06313-28. Parker E, Thomas J, Roper KJ, Ijaz S, Edwards T, Marchesin F, Katsanovskaja K, Lett L, Jones C, Hardwick HE, Davis C, Vink E, McDonald SE, Moore SC, Dicks S, Jegatheesan K, Cook NJ, Hope J, Cherepanov P, ..., Investigators IC. Sars-Cov-2 Antibody Responses Associate with Sex, Age and Disease Severity in Previously Uninfected People Admitted to Hospital with Covid-19: An Isaric4c Prospective Study. Front Immunol. 2023;14:1146702. doi: 10.3389/fimmu.2023.1146702. PubMed PMID: 37056776; PMCID: PMC10087108.
DOI: https://doi.org/10.3389/fimmu.2023.11467029. Moser C, Li JZ, Eron JJ, Aga E, Daar ES, Wohl DA, Coombs RW, Javan AC, Bender Ignacio RA, Jagannathan P, Ritz J, Sieg SF, Parikh UM, Hughes MD, Currier JS, Smith DM, Chew KW, Team A-AS. Predictors of Sars-Cov-2 Rna from Nasopharyngeal Swabs and Concordance with Other Compartments in Nonhospitalized Adults with Mild to Moderate Covid-19. Open Forum Infect Dis. 2022;9(11):ofac618. doi: 10.1093/ofid/ofac618. PubMed PMID: 36467293; PMCID: PMC9709705.
DOI: https://doi.org/10.1093/ofid/ofac61810. Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ, Team A-AS. Symptom and Viral Rebound in Untreated Sars-Cov-2 Infection. Ann Intern Med. 2023;176(3):348-54. doi: 10.7326/M22-2381. PubMed PMID: 36802755; PMCID: PMC10052317.
11. Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D’Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES, Team A-AS. Safety and Efficacy of Combination Sars-Cov-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients with Covid-19. Ann Intern Med. 2023;176(5):658-66. doi: 10.7326/M22-3428. PubMed PMID: 37068272; PMCID: PMC10150320.
12. Gianella S, Rawlings SA, Dobrowolski C, Nakazawa M, Chaillon A, Strain M, Layman L, Caballero G, Scully E, Scott B, Pacis C, Weber KM, Landay A, Anderson C, Karn J. Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size during Aging. Clin Infect Dis. 2022;75(1):73-80. doi: 10.1093/cid/ciab873. PubMed PMID: 34612493; PMCID: PMC9402699.
DOI: https://doi.org/10.1093/cid/ciab87313. Das B, Dobrowolski C, Luttge B, Valadkhan S, Chomont N, Johnston R, Bacchetti P, Hoh R, Gandhi M, Deeks SG, Scully E, Karn J. Estrogen Receptor-1 Is a Key Regulator of Hiv-1 Latency That Imparts Gender-Specific Restrictions on the Latent Reservoir. Proc Natl Acad Sci U S A. 2018;115(33):E7795-E804. doi: 10.1073/pnas.1803468115. PubMed PMID: 30061382; PMCID: PMC6099847.
DOI: https://doi.org/10.1073/pnas.180346811514. Giurgea LT, Cervantes-Medina A, Walters KA, Scherler K, Han A, Czajkowski LM, Baus HA, Hunsberger S, Klein SL, Kash JC, Taubenberger JK, Memoli MJ. Sex Differences in Influenza: The Challenge Study Experience. J Infect Dis. 2022;225(4):715-22. doi: 10.1093/infdis/jiab422. PubMed PMID: 34423369; PMCID: PMC8844587.
DOI: https://doi.org/10.1093/infdis/jiab42215. Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, Xie G, Lin S, Wang R, Yang X, Chen W, Wang Q, Zhang D, Liu Y, Gong R, Ma Z, Lu S, Xiao Y, Gu Y, Zhang J, Yao H, Xu K, Lu X, Wei G, Zhou J, Fang Q, Cai H, Qiu Y, Sheng J, Chen Y, Liang T. Viral Load Dynamics and Disease Severity in Patients Infected with Sars-Cov-2 in Zhejiang Province, China, January-March 2020: Retrospective Cohort Study. BMJ. 2020;369:m1443. doi: 10.1136/bmj.m1443. PubMed PMID: 32317267; PMCID: PMC7190077.
DOI: https://doi.org/10.1136/bmj.m144316. Bolze A, Luo S, White S, Cirulli ET, Wyman D, Dei Rossi A, Machado H, Cassens T, Jacobs S, Schiabor Barrett KM, Tanudjaja F, Tsan K, Nguyen J, Ramirez JM, 3rd, Sandoval E, Wang X, Wong D, Becker D, Laurent M, Lu JT, Isaksson M, Washington NL, Lee W. Sars-Cov-2 Variant Delta Rapidly Displaced Variant Alpha in the United States and Led to Higher Viral Loads. Cell Rep Med. 2022;3(3):100564. doi: 10.1016/j.xcrm.2022.100564. PubMed PMID: 35474739; PMCID: PMC8922438.
DOI: https://doi.org/10.1016/j.xcrm.2022.10056417. He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X, Mo X, Chen Y, Liao B, Chen W, Hu F, Zhang Q, Zhong M, Wu Y, Zhao L, ..., Leung GM. Temporal Dynamics in Viral Shedding and Transmissibility of Covid-19. Nat Med. 2020. doi: 10.1038/s41591-020-0869-5. PubMed PMID: 32296168.
18. Vegeto E, Cuzzocrea S, Crisafulli C, Mazzon E, Sala A, Krust A, Maggi A. Estrogen Receptor-Alpha as a Drug Target Candidate for Preventing Lung Inflammation. Endocrinology. 2010;151(1):174-84. doi: 10.1210/en.2009-0876. PubMed PMID: 19952273; PMCID: PMC2803150.
DOI: https://doi.org/10.1210/en.2009-087619. Nadkarni S, McArthur S. Oestrogen and Immunomodulation: New Mechanisms That Impact on Peripheral and Central Immunity. Curr Opin Pharmacol. 2013;13(4):576-81. doi: 10.1016/j.coph.2013.05.007. PubMed PMID: 23731522.
DOI: https://doi.org/10.1016/j.coph.2013.05.00720. Solis O, Beccari AR, Iaconis D, Talarico C, Ruiz-Bedoya CA, Nwachukwu JC, Cimini A, Castelli V, Bertini R, Montopoli M, Cocetta V, Borocci S, Prandi IG, Flavahan K, Bahr M, Napiorkowski A, Chillemi G, Ooka M, Yang X, Zhang S, Xia M, Zheng W, Bonaventura J, Pomper MG, Hooper JE, Morales M, Rosenberg AZ, Nettles KW, Jain SK, Allegretti M, Michaelides M. The Sars-Cov-2 Spike Protein Binds and Modulates Estrogen Receptors. Sci Adv. 2022;8(48):eadd4150. doi: 10.1126/sciadv.add4150. PubMed PMID: 36449624; PMCID: PMC9710872.
DOI: https://doi.org/10.1126/sciadv.add415021. Hastie E, Amogan H, Looney D, Mehta SR. Association between Sars-Cov-2 Viral Load and Patient Symptoms and Clinical Outcomes Using Droplet Digital Pcr. Viruses. 2023;15(2). doi: 10.3390/v15020446. PubMed PMID: 36851660; PMCID: PMC9961727.
DOI: https://doi.org/10.3390/v1502044622. Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs RW, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 Rna Levels Are Associated with Timing of Symptom Resolution in the Activ-2 Trial of Nonhospitalized Adults with Coronavirus Disease 2019. Clin Infect Dis. 2023;76(4):734-7. doi: 10.1093/cid/ciac818. PubMed PMID: 36210483; PMCID: PMC9619579.
DOI: https://doi.org/10.1093/cid/ciac81823. Killingley B, Mann AJ, Kalinova M, Boyers A, Goonawardane N, Zhou J, Lindsell K, Hare SS, Brown J, Frise R, Smith E, Hopkins C, Noulin N, Londt B, Wilkinson T, Harden S, McShane H, Baillet M, Gilbert A, Jacobs M, Charman C, Mande P, Nguyen-Van-Tam JS, Semple MG, Read RC, Ferguson NM, Openshaw PJ, Rapeport G, Barclay WS, Catchpole AP, Chiu C. Safety, Tolerability and Viral Kinetics during Sars-Cov-2 Human Challenge in Young Adults. Nat Med. 2022;28(5):1031-41. doi: 10.1038/s41591-022-01780-9. PubMed PMID: 35361992.
DOI: https://doi.org/10.1038/s41591-022-01780-9